3646 results for «596»

Filter By

3646 results

Sirolimus coated balloon: expanding the scope of coronary artery disease treatment

07 Oct 2022 – From AICT-ASIAPCR 2022

Consult this session to understand the technology and scientific evidence of the novel sirolimus drug-coated balloon, to learn its utility for PCI in a variety of lesion and patient subsets and to understand the evidence and outcomes in real-world patients.

Sirolimus coated balloon: expanding the scope of coronary artery disease treatment

Treatment of small vessel disease - To stent or not to stent?

07 Oct 2022 – From AICT-AsiaPCR 2022

Consult this session if you want to learn the tips and tricks to perform a small vessel disease intervention and to discuss the pros and cons of treating small vessel disease with DCB and/or DES.

Treatment of small vessel disease - To stent or not to stent?

AsiaPCR/SingLIVE 2017: Opening Ceremony

19 Jan 2017 – From AsiaPCR/SingLIVE 2017

Consult the Opening ceremony of the AsiaPCR/SingLIVE 2017 course edition, the Chien Foundation Award for outstanding lectureship and lifetime achievement in PCI is awarded to Prof. A. Seth.

Upendra Kaul

Chairperson

Upendra Kaul
AsiaPCR/SingLIVE 2017:

AsiaPCR/SingLIVE 2017: closing Ceremony and Awards

21 Jan 2017 – From AsiaPCR/SingLIVE 2017

Consult the Closing ceremony and awards session from AsiaPCR/SingLIVE 2017, where W. Wijns addresses the subject of what to expect in the field of Interventional Cardiology in 2017, and the speakers present the award winners of this year's best clinical cases namely R. Fukuhara, Japan, W....

Prof. Tian-Hai Koh

Chairperson

Tian Hai Koh
Rosli Mohd Ali

Chairperson

Mohd Ali Rosli
AsiaPCR/SingLIVE 2017:

The RELIEVE-HF study: is an atrial septal shunt beneficial in HFrEF?

07 Apr 2024

Charles Fauvel provides his take on the RELIEVE-HF study outcomes presented by Gregg W. Stone at ACC.24 in Atlanta.

Charles Fauvel

Author

Charles Fauvel
The RELIEVE-HF study: is an atrial septal shunt beneficial in HFrEF?

NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome

02 Sep 2025

Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...

Daniele Giacoppo

Author

Daniele Giacoppo
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
Didn’t find what you were looking for?